NINDS BPN Preclinical Testing and Toxicology Program
Award Notice Posted
- Solicitation number
- A75N98026R00138
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Sri International
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HHSN271201600006I Federal IDV award
- NAICS code
- Not on record
- PSC
- Not on record
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Neurological Disorders and Stroke (NINDS), under the National Institutes of Health, extended the ordering period on four existing IDIQ contracts for the Blueprint Neurotherapeutics Network (BPN) Preclinical Testing and Toxicology Program (PTTP) through September 12, 2027—a one-year extension effective September 13, 2026—with no cost to the government and no changes to contract terms, conditions, scope, or ceiling values.
The four incumbent contractors are SRI International, Southern Research, IIT Research Institute (IITRI), and University of Illinois Chicago Toxicology Research Laboratory (TRL). Each contract holds a maximum value of $174.47 million; $147.04 million remains available for task orders across both performance areas: Management and Operations Support and Pharmacology and Toxicology Studies. Services include analytical method development, in vivo and in vitro pharmacokinetic studies, preclinical acute and chronic toxicity evaluations, safety pharmacology studies, genotoxicity and carcinogenicity assessments, and ADMET assays.
The extension was made under unusual and compelling urgency authority (41 U.S.C. 3304(a)(2)) because these four contractors are the sole current PTTP IDIQ holders with GLP-IND-enabling capabilities and validated protocols. Transitioning work to new contractors would risk approximately $9–10 million in grant investments and cause GLP toxicology test article batches to expire before use. A follow-on competitive procurement is anticipated to award in August/September 2027 following solicitation release in December 2026.
Notice text
NINDS Blueprint Neurotherapeutics Network (BPN) extended the ordering period of four (4) existing Indefinite Delivery, Indefinite Quantity (IDIQ) contracts awarded under the BPN Preclinical Testing and Toxicology Program (PTTP), with the contractors listed below. This action extends the ordering period by one year, from September 13, 2026, through September 12, 2027. This is a no-cost modification; no other changes to the contracts' terms, conditions, scope, or ceiling value are being made.
SRI International
HHSN271201600006I
Southern Research
HHSN271201600007I
IIT Research Institute (IITRI)
75N95021D00026
University of Illinois Chicago, Toxicology Research Laboratory (TRL)
75N95022D00026
Please refer to the attached justification for additional information.
Awarded contract HHSN271201600006I to SRI INTERNATIONAL for 0.00 on 2026-09-12.
Files
| File | Type | Posted |
|---|---|---|
| NINDS PTTP IDIQ Ext._JOFOC_Final for Approval_oamp_redacted_Redacted.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity